<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Gianotti-Crosti syndrome (papular acrodermatitis)</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Gianotti-Crosti syndrome (papular acrodermatitis)</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Gianotti-Crosti syndrome (papular acrodermatitis)</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Antonio A T Chuh, MD, FRCP, FRCPCH</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Moise L Levy, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Abena O Ofori, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 26, 2021.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Gianotti-Crosti syndrome (GCS), also known as papular acrodermatitis, papular acrodermatitis of childhood, and infantile papular acrodermatitis, is a self-limited skin disorder that most often occurs in young children. Viral infections are common precipitating factors for GCS.</p><p>GCS typically manifests as a symmetric, papular eruption. Classic sites of involvement include the cheeks, buttocks, and extensor surfaces of the forearms and legs  (<a class="graphic graphic_picture graphicRef67780 graphicRef95217 graphicRef95218 graphicRef95219 graphicRef95220 graphicRef95221" href="/z/d/graphic/67780.html" rel="external">picture 1A-F</a>). GCS may be pruritic or asymptomatic, and papules typically resolve spontaneously within two months. Occasionally, GCS persists for longer periods.</p><p>The etiology, clinical manifestations, diagnosis, and management of GCS will be reviewed here. Other uncommon exanthems that primarily occur in children and in association with viral infections are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/13739.html" rel="external">"Atypical exanthems in children"</a>.)</p><p class="headingAnchor" id="H2639053324"><span class="h1">HISTORY AND TERMINOLOGY</span><span class="headingEndMark"> — </span>Features consistent with GCS were first described by Gianotti and Crosti in the 1950s [<a href="#rid1">1,2</a>]. The disorder was initially considered limited to infants and children but has since been recognized in adolescents and adults [<a href="#rid3">3-5</a>]. </p><p>The original description of GCS consisted of three cardinal manifestations [<a href="#rid1">1,2,6-8</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Nonrelapsing erythemato-papular dermatitis localized to the face and limbs, lasting approximately three weeks</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Paracortical hyperplasia of lymph nodes</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute hepatitis, usually anicteric, which could last for months and progress to chronic liver disease</p><p></p><p>However, it is now accepted that neither lymphadenopathy nor hepatitis is mandatory for the diagnosis of GCS, and the duration of the condition can vary. Some authors have utilized the term "Gianotti-Crosti disease" to refer to GCS that occurs specifically in association with hepatitis B virus infection [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H3"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>GCS occurs worldwide. The incidence and prevalence are unknown. Because many children with GCS are likely diagnosed with a "viral rash" or "nonspecific viral exanthem," GCS is probably underdiagnosed [<a href="#rid10">10</a>]. (See <a class="local">'Differential diagnosis'</a> below.)</p><p>GCS primarily affects children younger than five years of age. During childhood, there does not appear to be a sex predilection [<a href="#rid11">11,12</a>]. In contrast, case reports suggest that, among adults, females may be more likely to develop GCS than males [<a href="#rid9">9</a>].</p><p>Most reports of GCS describe isolated cases. However, outbreaks have been described in association with hepatitis B virus infection, Epstein-Barr virus infection, and idiopathic cases [<a href="#rid13">13-18</a>]. </p><p class="headingAnchor" id="H4"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>The epidemiologic features (eg, young age of onset, equal sex distribution in children, and occurrences of outbreaks) support an infectious etiology for GCS [<a href="#rid19">19</a>]. Viral infections are considered the most common etiologic agents.</p><p class="headingAnchor" id="H2345427320"><span class="h2">Viral infections</span><span class="headingEndMark"> — </span>GCS usually occurs in association with a viral illness, most often Epstein-Barr virus (EBV) or hepatitis B virus (HBV) infection [<a href="#rid20">20</a>]. Case reports, case series, and retrospective studies support the association between EBV [<a href="#rid11">11,21-30</a>] and HBV infection [<a href="#rid13">13-15,31-35</a>]. Of note, HBV is an uncommon cause of GCS in locales where vaccination against HBV infection during infancy is routine, such as the United States [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/z/d/html/8283.html" rel="external">"Clinical manifestations and treatment of Epstein-Barr virus infection"</a> and  <a class="medical medical_review" href="/z/d/html/5943.html" rel="external">"Clinical manifestations and diagnosis of hepatitis B virus infection in children and adolescents"</a>.)</p><p>GCS is less commonly reported in association with other viral pathogens. Examples include enteroviruses [<a href="#rid36">36,37</a>], cytomegalovirus [<a href="#rid38">38-41</a>], parvovirus [<a href="#rid42">42,43</a>], parainfluenza virus [<a href="#rid44">44,45</a>], hepatitis A virus [<a href="#rid46">46,47</a>], rotavirus [<a href="#rid48">48,49</a>], molluscum contagiosum [<a href="#rid42">42,50</a>], respiratory syncytial virus [<a href="#rid37">37</a>], HIV [<a href="#rid51">51</a>], and human herpesvirus 6 [<a href="#rid52">52-54</a>].</p><p class="headingAnchor" id="H986595720"><span class="h2">Other associations</span><span class="headingEndMark"> — </span>Occasionally, GCS occurs in association with vaccination or bacterial infections. GCS has occurred following the administration of various antiviral vaccines, including vaccination against influenza [<a href="#rid55">55-58</a>], measles-mumps-rubella [<a href="#rid59">59</a>], hepatitis B [<a href="#rid60">60,61</a>], polio [<a href="#rid62">62,63</a>], hepatitis A [<a href="#rid64">64</a>], Japanese encephalitis [<a href="#rid65">65</a>], and varicella zoster virus infections [<a href="#rid66">66</a>]. One of the largest studies to evaluate the relationship between GCS and vaccination assessed 116 children diagnosed with GCS in close proximity to scheduled national days for receipt of the oral polio vaccine [<a href="#rid63">63</a>]. The study found that GCS was more often present one month after scheduled vaccination days (105 children, 90 percent) than one month prior to these days (11 children, 10 percent). Additional study is necessary to clarify the relationship between GCS and vaccines. </p><p>Associations between the development of GCS and bacterial infections have been documented in case reports, including <em>Mycoplasma pneumoniae</em> [<a href="#rid67">67,68</a>], beta-hemolytic streptococci [<a href="#rid37">37</a>], <em>Bartonella henselae</em> [<a href="#rid69">69</a>], and <em>Borrelia burgdorferi</em> [<a href="#rid70">70</a>].</p><p class="headingAnchor" id="H9"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The pathogenesis of GCS, including the reason for the acral distribution, is unknown. One hypothesis suggests that the clinical manifestations result from a delayed hypersensitivity reaction to viral infections [<a href="#rid71">71</a>].</p><p>The significance of immunoglobulin E (IgE)-mediated immunity in the pathogenesis of GCS and other viral exanthems is an area of investigation. GCS appears to be associated with atopy, which is characterized by the production of specific IgE following allergen exposure. A case-control study found that children with GCS were more likely to have had atopic dermatitis and to have a family history of atopy than control children who were being evaluated for recurrent infections (24 versus 7 percent for atopic dermatitis and 52 versus 31 percent for family history of atopy) [<a href="#rid72">72</a>]. In another case-control study with 37 children with GCS and matched controls, atopic dermatitis was more common among children with GCS than without GCS (76 versus 24 percent), and children with GCS were more likely to have at least one atopic disorder (84 versus 51 percent) [<a href="#rid73">73</a>]. (See  <a class="medical medical_review" href="/z/d/html/83038.html" rel="external">"The relationship between IgE and allergic disease"</a>.)</p><p class="headingAnchor" id="H10"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>The clinical manifestations of GCS typically consist of the cutaneous eruption and findings related to the associated infection.</p><p class="headingAnchor" id="H11"><span class="h2">Cutaneous manifestations</span><span class="headingEndMark"> — </span>GCS classically presents as an acute, symmetric eruption of flat-topped, skin-colored or pink-brown papules or papulovesicles 1 to 10 mm in diameter that may coalesce into plaques  (<a class="graphic graphic_picture graphicRef67780 graphicRef95217 graphicRef95218 graphicRef95219 graphicRef95220 graphicRef95221" href="/z/d/graphic/67780.html" rel="external">picture 1A-F</a>) [<a href="#rid9">9,74</a>]. Although the face, buttocks, extensor aspects of forearms and legs, and feet are the predominant sites of involvement, involvement of the trunk does not exclude a diagnosis of GCS [<a href="#rid75">75</a>]. Truncal lesions are often more transient and fewer in number than acral lesions. Pruritus is usually mild to moderate but may be absent or severe.</p><p>The development of lesions at sites of skin trauma (ie, the Koebner phenomenon) may occur early in the course of GCS [<a href="#rid11">11,76</a>]. In addition, hemorrhagic lesions occasionally occur, particularly in areas subject to trauma [<a href="#rid9">9,74,76,77</a>]. It has been suggested that patients with petechial lesions are more likely to have hepatitis B virus infection [<a href="#rid78">78</a>]. However, the cutaneous findings of GCS are not a reliable indicator of the etiologic agent [<a href="#rid31">31</a>]. A vesiculobullous variant has also been reported in a child with Epstein-Barr virus (EBV) infection [<a href="#rid79">79</a>]. (See  <a class="medical medical_review" href="/z/d/html/5943.html" rel="external">"Clinical manifestations and diagnosis of hepatitis B virus infection in children and adolescents"</a>.)</p><p>GCS does not cause mucosal lesions. However, mucosal or cutaneous features of certain associated viral infections may accompany the cutaneous manifestations of GCS. As an example, patients with enterovirus-associated GCS may have oral mucosal or palmoplantar skin lesions. (See  <a class="medical medical_review" href="/z/d/html/96219.html" rel="external">"Hand, foot, and mouth disease and herpangina"</a>.)</p><p class="headingAnchor" id="H12"><span class="h2">Extracutaneous manifestations</span><span class="headingEndMark"> — </span>Patients with GCS may experience symptoms of an upper respiratory or gastrointestinal illness during the week before the onset of the rash [<a href="#rid9">9</a>]. The initial illness may have resolved by the time the child presents with cutaneous manifestations. Patients may also present with concurrent malaise, low-grade fever, or diarrhea [<a href="#rid9">9</a>]. </p><p>Lymphadenopathy occurs in 25 to 35 percent of patients, usually in the cervical, axillary, or inguinal regions [<a href="#rid11">11,80</a>]. The frequency of hepatic involvement is not known [<a href="#rid9">9</a>]. When hepatitis is present, it usually is anicteric (without clinically recognized jaundice) [<a href="#rid8">8,81</a>]. Splenomegaly may occur but is uncommon [<a href="#rid9">9</a>]. (See <a class="local">'Diagnosis'</a> below.)</p><p class="headingAnchor" id="H13"><span class="h2">Laboratory findings</span><span class="headingEndMark"> — </span>There are no laboratory features characteristic of GCS. Patients may have modest lymphocytosis or lymphopenia [<a href="#rid9">9</a>]. Liver enzymes may be elevated in patients with EBV, cytomegalovirus, or hepatitis-associated disease. </p><p class="headingAnchor" id="H14"><span class="h1">COURSE</span><span class="headingEndMark"> — </span>Most children with GCS have an excellent prognosis, although the course may be prolonged [<a href="#rid9">9</a>]. Spontaneous remission without active intervention is the rule. </p><p>During the initial two to three weeks, new papules and papulovesicles continue to occur, and the areas of involvement expand. The distribution is most classic in the middle phase of the disease.</p><p>GCS usually persists for 10 days to 6 months; however, durations ranging from 5 days to 12 months have been reported [<a href="#rid80">80</a>]. Most patients achieve resolution of papules and associated pruritus within two weeks to two months. </p><p>Near the end of the course, slow resolution of the skin lesions occurs. Recurrences are rare [<a href="#rid82">82</a>]. When present, lymphadenopathy and hepatomegaly (or hepatosplenomegaly) usually take longer to resolve than the cutaneous lesions [<a href="#rid33">33,76</a>].</p><p class="headingAnchor" id="H15"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Postinflammatory hypopigmentation or hyperpigmentation often follows resolution of the skin lesions in children with highly pigmented skin and can persist for up to six months, but eventually resolves [<a href="#rid9">9,83</a>]. Permanent scarring is uncommon.</p><p>Other potential complications are related to the underlying etiology. (See  <a class="medical medical_review" href="/z/d/html/8283.html" rel="external">"Clinical manifestations and treatment of Epstein-Barr virus infection", section on 'Complications'</a> and  <a class="medical medical_review" href="/z/d/html/5943.html" rel="external">"Clinical manifestations and diagnosis of hepatitis B virus infection in children and adolescents"</a>.)</p><p class="headingAnchor" id="H4043537709"><span class="h1">HISTOPATHOLOGY</span><span class="headingEndMark"> — </span>The histopathologic findings of GCS are nonspecific. Typical findings include focal, epidermal spongiosis and parakeratosis with perivascular, lymphocytic infiltrates in the upper dermis [<a href="#rid84">84</a>].</p><p class="headingAnchor" id="H16"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>GCS can usually be diagnosed based upon the history and physical examination. A skin biopsy is not usually necessary but may be useful in challenging cases. (See <a class="local">'Differential diagnosis'</a> below.)</p><p>The establishment of diagnostic criteria would help to facilitate the clinical diagnosis of GCS and future studies of the disease. It remains to be determined whether proposed, diagnostic criteria are the ideal criteria for the diagnosis of this disease [<a href="#rid85">85</a>]. More studies are necessary to assess the criteria-rated validity, test-test intraclinician reliability, and interclinician reliability [<a href="#rid86">86</a>].</p><p class="headingAnchor" id="H17"><span class="h2">History and physical examination</span><span class="headingEndMark"> — </span>The history and physical examination should include an assessment of preceding or concurrent constitutional symptoms as well as the time course, distribution, and morphology of the eruption. A full skin examination should be performed.</p><p>A diagnosis of GCS is strongly suggested by the acute onset of a symmetrically distributed, papular or papulovesicular eruption in a young child that primarily involves the face, buttocks, and/or extensor surfaces of the extremities and does not have another identifiable cause  (<a class="graphic graphic_picture graphicRef67780 graphicRef95217 graphicRef95218 graphicRef95219 graphicRef95220 graphicRef95221" href="/z/d/graphic/67780.html" rel="external">picture 1A-F</a>). The presence of extracutaneous signs and symptoms (eg, malaise, fever, diarrhea, lymphadenopathy) is variable.</p><p class="headingAnchor" id="H18"><span class="h2">Skin biopsy</span><span class="headingEndMark"> — </span>The histopathologic findings of GCS are nonspecific and cannot confirm the diagnosis. However, a skin biopsy may be necessary to exclude other diagnoses in atypical presentations (eg, atypical lesion morphology or distribution, or lack of spontaneous resolution within six months). A 4 mm punch biopsy is usually sufficient. (See <a class="local">'Histopathology'</a> above and <a class="local">'Differential diagnosis'</a> below and  <a class="medical medical_review" href="/z/d/html/5577.html" rel="external">"Skin biopsy techniques"</a>.)</p><p class="headingAnchor" id="H19"><span class="h1">EVALUATION FOR UNDERLYING DISORDERS</span><span class="headingEndMark"> — </span>The decision to proceed with laboratory tests to identify an etiologic agent for GCS should be made on an individual basis. Laboratory testing to identify an etiologic agent is not necessary for many patients. (See <a class="local">'Etiology'</a> above.)</p><p>However, testing of patients with GCS for specific viral infections is warranted in some scenarios, such as to identify patients who may benefit from close monitoring or treatment of a suspected underlying condition. GCS may be the only clinical manifestation of acute hepatitis B virus (HBV) infection in infants and young children; therefore, testing for HBV infection is particularly appropriate for patients with risk factors for HBV infection. Laboratory testing to screen for Epstein-Barr virus (EBV) infection is generally unnecessary in the absence of other indications for EBV testing, as supportive therapy is often sufficient. (See  <a class="medical medical_review" href="/z/d/html/5943.html" rel="external">"Clinical manifestations and diagnosis of hepatitis B virus infection in children and adolescents", section on 'Epidemiology'</a> and  <a class="medical medical_review" href="/z/d/html/5943.html" rel="external">"Clinical manifestations and diagnosis of hepatitis B virus infection in children and adolescents", section on 'Screening'</a>.)</p><p>Testing to identify an etiologic agent may also be of value in immunocompromised patients or in patients with close contact with immunocompromised individuals or pregnant women [<a href="#rid87">87</a>]. Moreover, investigative testing may also be warranted when extracutaneous clinical findings (eg, hepatomegaly) require further work-up. The clinical presentation directs the approach to evaluation.</p><p class="headingAnchor" id="H20"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The constellation of clinical features in GCS usually allows the diagnosis to be made relatively easily [<a href="#rid9">9</a>]. However, other conditions may warrant consideration, particularly in the setting of atypical presentations. Assessment of the course, associated symptoms, and lesion morphology and distribution is usually helpful for distinguishing GCS [<a href="#rid76">76</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Erythema infectiosum </strong>− Erythema infectiosum (EI; also known as "fifth disease") is a common childhood exanthem caused by parvovirus B19. Like GCS, EI begins with nonspecific prodromal illness and acral eruption. However, the rash of EI, which begins on the cheeks  (<a class="graphic graphic_picture graphicRef52251" href="/z/d/graphic/52251.html" rel="external">picture 2</a>) and spreads to the extremities  (<a class="graphic graphic_picture graphicRef122702" href="/z/d/graphic/122702.html" rel="external">picture 3</a>), often has a lacy, reticulated appearance. (See  <a class="medical medical_review" href="/z/d/html/8272.html" rel="external">"Clinical manifestations and diagnosis of parvovirus B19 infection", section on 'Erythema infectiosum'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Erythema multiforme </strong>− Erythema multiforme (EM) typically affects adolescents and young adults, but may also occur in children [<a href="#rid74">74</a>]. EM is often caused by herpes simplex virus or <em>Mycoplasma</em> infection. Although target lesions are characteristic of EM  (<a class="graphic graphic_picture graphicRef57894" href="/z/d/graphic/57894.html" rel="external">picture 4</a>), the lesions may be papular early in the course. Mucosal lesions are present in some children with EM and may help to distinguish it from GCS. (See  <a class="medical medical_review" href="/z/d/html/5559.html" rel="external">"Erythema multiforme: Pathogenesis, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hand, foot, and mouth disease </strong>− Hand, foot, and mouth disease (HFMD) is a common childhood illness that is usually caused by the group A coxsackieviruses. HFMD is characterized by fever; oral vesicles on the buccal mucosa and tongue; and peripherally distributed, small, tender, cutaneous macules, papules, or vesicles on the hands, feet, buttocks, and (less commonly) genitalia  (<a class="graphic graphic_picture graphicRef58566 graphicRef71314 graphicRef53423" href="/z/d/graphic/58566.html" rel="external">picture 5A-C</a>). The mucosal lesions and relatively short clinical course of HFMD distinguish it from GCS. (See  <a class="medical medical_review" href="/z/d/html/96219.html" rel="external">"Hand, foot, and mouth disease and herpangina", section on 'Hand, foot, and mouth disease'</a> and  <a class="medical medical_review" href="/z/d/html/96219.html" rel="external">"Hand, foot, and mouth disease and herpangina"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Scabies </strong>− Scabies is an infestation of the skin by the mite <em>Sarcoptes scabiei</em> that results in an intense pruritus and small, erythematous papules, pustules, or vesicles, often in a characteristic distribution  (<a class="graphic graphic_picture graphicRef56862 graphicRef54315" href="/z/d/graphic/56862.html" rel="external">picture 6A-B</a>). The degree of pruritus distinguishes scabies from GCS; pruritus associated with GCS is not usually severe. Characteristic scabies mite burrows may also be visible in patients with scabies. (See  <a class="medical medical_review" href="/z/d/html/4038.html" rel="external">"Scabies: Epidemiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Papular urticaria </strong>− Papular urticaria (also known as insect bite-induced hypersensitivity reaction) is defined by chronic or recurrent eruptions of papules, vesicles, target lesions, or wheals caused by hypersensitivity to insect bites (eg, fleas, mosquitoes, bedbugs, mites) in children. The lesions are symmetric, usually grouped in crops or clusters on exposed areas, and may take weeks to years to resolve. (See  <a class="medical medical_review" href="/z/d/html/4088.html" rel="external">"Insect and other arthropod bites", section on 'Papular urticaria'</a>.)</p><p></p><p>Less common conditions to consider in the differential diagnosis of GCS include lichen planus, drug eruptions, papular-purpuric gloves and socks syndrome (PPGSS), and immunoglobulin A (IGA) vasculitis (Henoch-Schönlein purpura  (<a class="graphic graphic_picture graphicRef72094" href="/z/d/graphic/72094.html" rel="external">picture 7</a>)). Petechial or purpuric lesions should prompt consideration of PPGSS and IgA vasculitis. (See  <a class="medical medical_review" href="/z/d/html/13739.html" rel="external">"Atypical exanthems in children", section on 'Papular-purpuric gloves and socks syndrome'</a> and  <a class="medical medical_review" href="/z/d/html/6406.html" rel="external">"IgA vasculitis (Henoch-Schönlein purpura): Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H21"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>GCS is a self-limited condition that can typically be managed with supportive therapy to minimize pruritus, when present. In addition, patients or caregivers of patients of GCS often benefit from a discussion of the diagnosis, expected course, and prognosis of GCS. (See <a class="local">'Course'</a> above.)</p><p class="headingAnchor" id="H17596272"><span class="h2">Pruritus</span><span class="headingEndMark"> — </span>Interventions for GCS have not been evaluated in randomized trials. Clinical experience suggests that topical emollients provide adequate relief for most individuals. For patients with significant pruritus, lotions containing ingredients such as calamine, <a class="drug drug_general" data-topicid="10226" href="/z/d/drug information/10226.html" rel="external">pramoxine</a>, menthol, or <a class="drug drug_general" data-topicid="104178" href="/z/d/drug information/104178.html" rel="external">camphor</a> may help to alleviate pruritus. Low- or medium-potency topical corticosteroids have also been utilized. However, the ability of topical corticosteroids to alter the disease course has not been confirmed  (<a class="graphic graphic_table graphicRef62402" href="/z/d/graphic/62402.html" rel="external">table 1</a>) [<a href="#rid44">44</a>]. The administration of a sedating antihistamine may be helpful when the pruritus interferes with sleep. (See  <a class="medical medical_review" href="/z/d/html/131632.html" rel="external">"Pruritus: Therapies for generalized pruritus", section on 'Elimination of aggravating factors'</a>.)</p><p class="headingAnchor" id="H26"><span class="h2">Return to daycare or school</span><span class="headingEndMark"> — </span>Exclusion from daycare, school, or other activities is unnecessary for most children with GCS. The need for any infection precautions is based upon the risks of transmission of the underlying infectious disease. (See <a class="local">'Etiology'</a> above.)</p><p class="headingAnchor" id="H4064801336"><span class="h2">Indications for referral</span><span class="headingEndMark"> — </span>Referral to a pediatric dermatologist may be beneficial if the diagnosis is uncertain or the disease course is exceptionally prolonged (eg, longer than six months).</p><p class="headingAnchor" id="H28"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Gianotti-Crosti syndrome (GCS) is a self-limited cutaneous disorder that typically presents as a symmetric, papular eruption with an acral distribution. GCS primarily affects children younger than five years but can also occur in adolescents and adults. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>GCS usually occurs in association with a viral illness, such as infection with Epstein-Barr virus, hepatitis B virus, or other viruses. GCS associated with antiviral vaccines or bacterial infections and idiopathic GCS have also been reported. (See <a class="local">'Etiology'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis of GCS usually can be made based upon the patient history and physical findings. The characteristic presentation of GCS consists of symmetric, monomorphous, flat-topped, pink-brown or skin-colored papules or papulovesicles on the face, buttocks, feet, and extensor aspects of forearms and legs  (<a class="graphic graphic_picture graphicRef67780 graphicRef95217 graphicRef95218 graphicRef95219 graphicRef95220 graphicRef95221" href="/z/d/graphic/67780.html" rel="external">picture 1A-F</a>). Pruritus may be present. (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Noncutaneous findings in patients with GCS may include malaise, low-grade fever, and diarrhea. Lymphadenopathy is present in a subset of patients. Hepatitis, when present, is usually anicteric. (See <a class="local">'Extracutaneous manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>GCS typically resolves spontaneously within two months. Supportive care for associated pruritus, such as emollients, topical antipruritic agents, and oral sedating antihistamines, is usually sufficient. Exclusion from daycare or school is not necessary for most children with GCS. (See <a class="local">'Management'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">GIANOTTI F. [Report on a special case of toxic infection characterized by a desquamative erythemato-infiltrative eruption with lenticular foci and a selective localization at the extremities]. Soc Ital Dermatol Sifilogr Sezioni Interprov Soc Ital Dermatol Sifilogr 1955; 96:678.</a></li><li><a class="nounderline abstract_t">CROSTI A, GIANOTTI F. [Eruptive dermatosis of probable viral origin situated on the acra]. Dermatologica 1957; 115:671.</a></li><li><a class="nounderline abstract_t">Claudy AL, Ortonne JP, Trepo C, Bugnon B. [Adult papular acrodermatitis (Gianotti's disease). Report of 3 cases]. Ann Dermatol Venereol 1977; 104:190.</a></li><li><a class="nounderline abstract_t">Niitsuma H, Ishii M, Ojima T, et al. [A case of acute hepatitis infected with hepatitis B virus during pregnancy and complicated by Gianotti-Crosti syndrome]. Nihon Shokakibyo Gakkai Zasshi 1999; 96:423.</a></li><li><a class="nounderline abstract_t">Gibbs S, Burrows N. Gianotti-Crosti syndrome in two unrelated adults. Clin Exp Dermatol 2000; 25:594.</a></li><li><a class="nounderline abstract_t">Gianotti F. [Viral anicteric hepatitis in infantile papular acrodermatitis]. Epatologia 1966; 12:171.</a></li><li><a class="nounderline abstract_t">Gianotti F. [Infantile papular acrodermatitis. Acrodermatitis papulosa and the infantile papulovesicular acrolocalized syndrome]. Hautarzt 1976; 27:467.</a></li><li><a class="nounderline abstract_t">Gianotti F. Papular acrodermatitis of childhood and other papulo-vesicular acro-located syndromes. Br J Dermatol 1979; 100:49.</a></li><li><a class="nounderline abstract_t">Brandt O, Abeck D, Gianotti R, Burgdorf W. Gianotti-Crosti syndrome. J Am Acad Dermatol 2006; 54:136.</a></li><li><a class="nounderline abstract_t">Jindal T, Arora VK. Gianotti-crosti syndrome. Indian Pediatr 2000; 37:683.</a></li><li><a class="nounderline abstract_t">Taïeb A, Plantin P, Du Pasquier P, et al. Gianotti-Crosti syndrome: a study of 26 cases. Br J Dermatol 1986; 115:49.</a></li><li><a class="nounderline abstract_t">Brown J, Rentiers P. The Gianotti-Crosti syndrome: a distrinctive exanthem. Can Med Assoc J 1969; 100:773.</a></li><li><a class="nounderline abstract_t">Toda G, Ishimaru Y, Mayumi M, Oda T. Infantile papular acrodermatitis (Gianotti's disease) and intrafamilial occurence of acute hepatitis B with jaundice: age dependency of clinical manifestations of hepatitis B virus infection. J Infect Dis 1978; 138:211.</a></li><li><a class="nounderline abstract_t">Ishimaru Y, Ishimaru H, Toda G, et al. An epidemic of infantile papular acrodermatitis (Gianotti's disease) in Japan associated with hepatitis-B surface antigen subtype ayw. Lancet 1976; 1:707.</a></li><li><a class="nounderline abstract_t">Kanzaki S, Kanda S, Terada K, et al. Detection of hepatitis B surface antigen subtype adr in an epidemic of papular acrodermatitis of childhood (Gianotti's disease). Acta Med Okayama 1981; 35:407.</a></li><li><a class="nounderline abstract_t">Baldari U, Monti A, Righini MG. An epidemic of infantile papular acrodermatitis (Gianotti-Crosti syndrome) due to Epstein-Barr virus. Dermatology 1994; 188:203.</a></li><li><a class="nounderline abstract_t">Yoshida M, Tsuda N, Morihata T, et al. Five patients with localized facial eruptions associated with Gianotti-Crosti syndrome caused by primary Epstein-Barr virus infection. J Pediatr 2004; 145:843.</a></li><li><a class="nounderline abstract_t">Demattei C, Zawar V, Lee A, et al. Spatial-temporal case clustering in children with Gianotti-Crosti syndrome. Systematic analysis led to the identification of a mini-epidemic. Eur J Pediat Dermatol 2006; 16:159.</a></li><li><a class="nounderline abstract_t">Chuh A, Zawar V, Sciallis GF, et al. Pityriasis Rosea, Gianotti-Crosti Syndrome, Asymmetric Periflexural Exanthem, Papular-Purpuric Gloves and Socks Syndrome, Eruptive Pseudoangiomatosis, and Eruptive Hypomelanosis: Do Their Epidemiological Data Substantiate Infectious Etiologies? Infect Dis Rep 2016; 8:6418.</a></li><li><a class="nounderline abstract_t">Leung AKC, Sergi CM, Lam JM, Leong KF. Gianotti-Crosti syndrome (papular acrodermatitis of childhood) in the era of a viral recrudescence and vaccine opposition. World J Pediatr 2019; 15:521.</a></li><li><a class="nounderline abstract_t">Smith KJ, Skelton H. Histopathologic features seen in Gianotti-Crosti syndrome secondary to Epstein-Barr virus. J Am Acad Dermatol 2000; 43:1076.</a></li><li><a class="nounderline abstract_t">Maeda S, Tsuda H, Haruki S, Mitsuto I. Atypical Epstein-Barr virus infection associated with Gianotti-Crosti syndrome and Bell's palsy. Pediatr Int 1999; 41:315.</a></li><li><a class="nounderline abstract_t">Drago F, Crovato F, Rebora A. Gianotti-Crosti syndrome as a presenting sign of EBV-induced acute infectious mononucleosis. Clin Exp Dermatol 1997; 22:301.</a></li><li><a class="nounderline abstract_t">Hofmann B, Schuppe HC, Adams O, et al. Gianotti-Crosti syndrome associated with Epstein-Barr virus infection. Pediatr Dermatol 1997; 14:273.</a></li><li><a class="nounderline abstract_t">Konno M. [An association between hepatitis-B antigen-negative infantile papular acrodermatitis and Epstein-Barr virus infection]. Hokkaido Igaku Zasshi 1989; 64:125.</a></li><li><a class="nounderline abstract_t">Snelder SM, Engels LK, van der Valk H, van Praag MC. [Skin disorder as an indication of viral infection]. Ned Tijdschr Geneeskd 2015; 159:A8708.</a></li><li><a class="nounderline abstract_t">Hall LD, Eminger LA, Hesterman KS, Heymann WR. Epstein-Barr virus: dermatologic associations and implications: part I. Mucocutaneous manifestations of Epstein-Barr virus and nonmalignant disorders. J Am Acad Dermatol 2015; 72:1.</a></li><li><a class="nounderline abstract_t">Al Dhaheri HS, Al Kaabi A, Kara Hamo Y, et al. Unusual Presentation of Gianotti-Crosti Syndrome due to Epstein-Barr Virus Infection. Case Rep Dermatol Med 2016; 2016:1017524.</a></li><li><a class="nounderline abstract_t">Babu TA, Arivazhahan A. Gianotti-Crosti Syndrome following immunization in an 18 months old child. Indian Dermatol Online J 2015; 6:413.</a></li><li><a class="nounderline abstract_t">Stojkovic-Filipovic J, Skiljevic D, Brasanac D, Medenica L. Gianotti-Crosti syndrome associated with Ebstein-Barr virus and Parvovirus B-19 coinfection in a male adult: case report and review of the literature. G Ital Dermatol Venereol 2016; 151:106.</a></li><li><a class="nounderline abstract_t">Caputo R, Gelmetti C, Ermacora E, et al. Gianotti-Crosti syndrome: a retrospective analysis of 308 cases. J Am Acad Dermatol 1992; 26:207.</a></li><li><a class="nounderline abstract_t">Colombo M, Rumi MG, Sagnelli E, et al. Acute hepatitis B in children with papular acrodermatitis. Pediatr Pathol 1986; 6:249.</a></li><li><a class="nounderline abstract_t">Lee S, Kim KY, Hahn CS, et al. Gianotti-Crosti syndrome associated with hepatitis B surface antigen (subtype adr). J Am Acad Dermatol 1985; 12:629.</a></li><li><a class="nounderline abstract_t">Claudy AL, Ortonne JP, Trepo C, Bugnon B. Papular acrodermatitis associated with hepatitis B virus infection. Arch Dermatol 1979; 115:931.</a></li><li><a class="nounderline abstract_t">Rubenstein D, Esterly NB, Fretzin D. The Gianotti-Crosti syndrome. Pediatrics 1978; 61:433.</a></li><li><a class="nounderline abstract_t">James WD, Odom RB, Hatch MH. Gianotti-Crosti-like eruption associated with coxsackievirus A-16 infection. J Am Acad Dermatol 1982; 6:862.</a></li><li><a class="nounderline abstract_t">Draelos ZK, Hansen RC, James WD. Gianotti-Crosti syndrome associated with infections other than hepatitis B. JAMA 1986; 256:2386.</a></li><li><a class="nounderline abstract_t">Tzeng GH, Hsu CY, Chen HC. Gianotti-Crosti syndrome associated with cytomegalovirus infection: report of one case. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1995; 36:139.</a></li><li><a class="nounderline abstract_t">Berant M, Naveh Y, Weissman I. Papular acrodermatitis with cytomegalovirus hepatitis. Arch Dis Child 1983; 58:1024.</a></li><li><a class="nounderline abstract_t">Haki M, Tsuchida M, Kotsuji M, et al. Gianotti-Crosti syndrome associated with cytomegalovirus antigenemia after bone marrow transplantation. Bone Marrow Transplant 1997; 20:691.</a></li><li><a class="nounderline abstract_t">Drago F, Javor S, Ciccarese G, Parodi A. Gianotti-Crosti syndrome as presenting sign of cytomegalovirus infection: A case report and a critical appraisal of its possible cytomegalovirus etiology. J Clin Virol 2016; 78:120.</a></li><li><a class="nounderline abstract_t">Carrascosa JM, Just M, Ribera M, Ferrándiz C. Papular acrodermatitis of childhood related to poxvirus and parvovirus B19 infection. Cutis 1998; 61:265.</a></li><li><a class="nounderline abstract_t">Léger F, Callens A, Machet MC. [Parvovirus B19 primo-infection and cold agglutinins]. Ann Dermatol Venereol 1997; 124:257.</a></li><li><a class="nounderline abstract_t">Boeck K, Mempel M, Schmidt T, Abeck D. Gianotti-Crosti syndrome: clinical, serologic, and therapeutic data from nine children. Cutis 1998; 62:271.</a></li><li><a class="nounderline abstract_t">Hergueta Lendínez R, Pozo García L, Alejo García A, et al. [Gianotti-Crosti syndrome due to a mixed infection produced by the mumps virus and the parainfluenza virus type 2]. An Esp Pediatr 1996; 44:65.</a></li><li><a class="nounderline abstract_t">Sagi EF, Linder N, Shouval D. Papular acrodermatitis of childhood associated with hepatitis A virus infection. Pediatr Dermatol 1985; 3:31.</a></li><li><a class="nounderline abstract_t">Pouillaude JM, Moulin G, Morlat C, François R. [Gianotti-Crosti's infantile papular acrodermatitis. Nosological relationship with viral hepatitis. A fatal outcome]. Pediatrie 1975; 30:351.</a></li><li><a class="nounderline abstract_t">Di Lernia V. Gianotti-Crosti syndrome related to rotavirus infection. Pediatr Dermatol 1998; 15:485.</a></li><li><a class="nounderline abstract_t">Di Lernia V, Ricci C. Skin manifestations with Rotavirus infections. Int J Dermatol 2006; 45:759.</a></li><li><a class="nounderline abstract_t">de la Torre C. Gianotti-Crosti syndrome following milkers' nodules. Cutis 2004; 74:316.</a></li><li><a class="nounderline abstract_t">Blauvelt A, Turner ML. Gianotti-Crosti syndrome and human immunodeficiency virus infection. Arch Dermatol 1994; 130:481.</a></li><li><a class="nounderline abstract_t">Yasumoto S, Tsujita J, Imayama S, Hori Y. Case report: Gianotti-Crosti syndrome associated with human herpesvirus-6 infection. J Dermatol 1996; 23:499.</a></li><li><a class="nounderline abstract_t">Chuh AA, Chan HH, Chiu SS, et al. A prospective case control study of the association of Gianotti-Crosti syndrome with human herpesvirus 6 and human herpesvirus 7 infections. Pediatr Dermatol 2002; 19:492.</a></li><li><a class="nounderline abstract_t">Terraneo L, Lava SA, Camozzi P, et al. Unusual Eruptions Associated with Mycoplasma pneumoniae Respiratory Infections: Review of the Literature. Dermatology 2015; 231:152.</a></li><li><a class="nounderline abstract_t">Cambiaghi S, Scarabelli G, Pistritto G, Gelmetti C. Gianotti-Crosti syndrome in an adult after influenza virus vaccination. Dermatology 1995; 191:340.</a></li><li><a class="nounderline abstract_t">Kwon NH, Kim JE, Cho BK, Park HJ. Gianotti-Crosti Syndrome Following Novel Influenza A (H1N1) Vaccination. Ann Dermatol 2011; 23:554.</a></li><li><a class="nounderline abstract_t">Lam JM. Atypical Gianotti-Crosti syndrome following administration of the AS03-adjuvanted H1N1 vaccine. J Am Acad Dermatol 2011; 65:e127.</a></li><li><a class="nounderline abstract_t">Kroeskop A, Lewis AB, Barril FA, Baribault KE. Gianotti-Crosti syndrome after H1N1-influenza vaccine. Pediatr Dermatol 2011; 28:595.</a></li><li><a class="nounderline abstract_t">Velangi SS, Tidman MJ. Gianotti-Crosti syndrome after measles, mumps and rubella vaccination. Br J Dermatol 1998; 139:1122.</a></li><li><a class="nounderline abstract_t">Andiran N, Sentürk GB, Bükülmez G. Combined vaccination by measles and hepatitis B vaccines: a new cause of Gianotti-Crosti syndrome. Dermatology 2002; 204:75.</a></li><li><a class="nounderline abstract_t">Karakaş M, Durdu M, Tuncer I, Cevlik F. Gianotti-Crosti syndrome in a child following hepatitis B virus vaccination. J Dermatol 2007; 34:117.</a></li><li><a class="nounderline abstract_t">Erkek E, Senturk GB, Ozkaya O, Bükülmez G. Gianotti-Crosti syndrome preceded by oral polio vaccine and followed by varicella infection. Pediatr Dermatol 2001; 18:516.</a></li><li><a class="nounderline abstract_t">Zawar V, Chuh A. A case-control study on the association of pulse oral poliomyelitis vaccination and Gianotti-Crosti syndrome. Int J Dermatol 2017; 56:75.</a></li><li><a class="nounderline abstract_t">Kolivras A, André J. Gianotti-Crosti syndrome following hepatitis A vaccination. Pediatr Dermatol 2008; 25:650.</a></li><li><a class="nounderline abstract_t">Kang NG, Oh CW. Gianotti-Crosti syndrome following Japanese encephalitis vaccination. J Korean Med Sci 2003; 18:459.</a></li><li><a class="nounderline abstract_t">Shibata T, Yanagishita T, Oshima Y, Watanabe D. Case of Gianotti-Crosti syndrome following varicella zoster virus vaccination. J Dermatol 2019; 46:e36.</a></li><li><a class="nounderline abstract_t">Angoulvant N, Grézard P, Wolf F, et al. [Acute Mycoplasma pneumoniae infection: new cause of Gianotti Crosti syndrome]. Presse Med 2000; 29:1287.</a></li><li><a class="nounderline abstract_t">Manoharan S, Muir J, Williamson R. Gianotti-Crosti syndrome in an adult following recent Mycoplasma pneumoniae infection. Australas J Dermatol 2005; 46:106.</a></li><li><a class="nounderline abstract_t">Silveira Cancela M, Valdés Tascón F, Pita Carretero J, et al. [Neonatal papular acrodermatitis (Gianotti-Crosti) and Bartonella henselae infection]. An Esp Pediatr 2000; 52:299.</a></li><li><a class="nounderline abstract_t">Baldari U, Cattonar P, Nobile C, et al. Infantile acrodermatitis of Gianotti-Crosti and Lyme borreliosis. Acta Derm Venereol 1996; 76:242.</a></li><li><a class="nounderline abstract_t">Magyarlaki M, Drobnitsch I, Schneider I. Papular acrodermatitis of childhood (Gianotti-Crosti disease). Pediatr Dermatol 1991; 8:224.</a></li><li><a class="nounderline abstract_t">Ricci G, Patrizi A, Neri I, et al. Gianotti-Crosti syndrome and allergic background. Acta Derm Venereol 2003; 83:202.</a></li><li><a class="nounderline abstract_t">Chuh A, Zawar V, Lee A, Sciallis G. Is Gianotti-Crosti Syndrome Associated with Atopy? A Case-Control Study and a Postulation on the Intrinsic Host Factors in Gianotti-Crosti Syndrome. Pediatr Dermatol 2016; 33:488.</a></li><li class="breakAll">Paller AS, Mancini AJ. The exanthematous diseases of childhood. In: Hurwitz Clinical Pediatric Dermatology: A Textbook of Skin Disorders of Childhood and Adolescence, 3rd ed, WB Saunders, 2006. p.423.</li><li><a class="nounderline abstract_t">Chuh AA. Truncal lesions do not exclude a diagnosis of Gianotti-Crosti syndrome. Australas J Dermatol 2003; 44:215.</a></li><li><a class="nounderline abstract_t">Tilly JJ, Drolet BA, Esterly NB. Lichenoid eruptions in children. J Am Acad Dermatol 2004; 51:606.</a></li><li><a class="nounderline abstract_t">Sarma N, Sarkar UK, Das MK, Das S. Hemorrhagic Gianotti-Crosti Syndrome in a One and Half Month old Infant: An Extremely Unusual Presentation. Indian J Dermatol 2013; 58:65.</a></li><li><a class="nounderline abstract_t">Spear KL, Winkelmann RK. Gianotti-Crosti syndrome. A review of ten cases not associated with hepatitis B. Arch Dermatol 1984; 120:891.</a></li><li><a class="nounderline abstract_t">Marcassi AP, Piazza CAD, Seize MBMP, Cestari SDCP. Atypical Gianotti-Crosti syndrome. An Bras Dermatol 2018; 93:265.</a></li><li><a class="nounderline abstract_t">Chuh A, Lee A, Zawar V. The diagnostic criteria of Gianotti-Crosti syndrome: are they applicable to children in India? Pediatr Dermatol 2004; 21:542.</a></li><li><a class="nounderline abstract_t">Colombo M, Gerber MA, Vernace SJ, et al. Immune response to hepatitis B virus in children with papular acrodermatitis. Gastroenterology 1977; 73:1103.</a></li><li><a class="nounderline abstract_t">Patrizi A, Di Lernia V, Neri I, Ricci G. An unusual case of recurrent Gianotti-Crosti syndrome. Pediatr Dermatol 1994; 11:283.</a></li><li><a class="nounderline abstract_t">Gabrielsen TO, Rajka G, Rustenberg B. [Acrodermatitis papulosa eruptiva infantum as a prodrome in hepatitis B infection]. Z Hautkr 1985; 60:1793.</a></li><li><a class="nounderline abstract_t">Milbradt R, Nasemann T. [Entity of the Gianotti-Crosti's syndrome and its relation to hepatitis B infection]. Hautarzt 1975; 26:471.</a></li><li><a class="nounderline abstract_t">Chuh A, Zawar V, Law M, Sciallis G. Gianotti-Crosti syndrome, pityriasis rosea, asymmetrical periflexural exanthem, unilateral mediothoracic exanthem, eruptive pseudoangiomatosis, and papular-purpuric gloves and socks syndrome: a brief review and arguments for diagnostic criteria. Infect Dis Rep 2012; 4:e12.</a></li><li><a class="nounderline abstract_t">Chuh A, Zawar V, Sciallis GF, Lee A. The diagnostic criteria of pityriasis rosea and Gianotti-Crosti syndrome - a protocol to establish diagnostic criteria of skin diseases. J R Coll Physicians Edinb 2015; 45:218.</a></li><li><a class="nounderline abstract_t">Nelson JS, Stone MS. Update on selected viral exanthems. Curr Opin Pediatr 2000; 12:359.</a></li></ol></div><div id="topicVersionRevision">Topic 4040 Version 18.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13305864" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : [Report on a special case of toxic infection characterized by a desquamative erythemato-infiltrative eruption with lenticular foci and a selective localization at the extremities].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13500859" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : [Eruptive dermatosis of probable viral origin situated on the acra].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/869460" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : [Adult papular acrodermatitis (Gianotti's disease). Report of 3 cases].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10332206" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : [A case of acute hepatitis infected with hepatitis B virus during pregnancy and complicated by Gianotti-Crosti syndrome].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11167968" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Gianotti-Crosti syndrome in two unrelated adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5988879" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : [Viral anicteric hepatitis in infantile papular acrodermatitis].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/993019" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : [Infantile papular acrodermatitis. Acrodermatitis papulosa and the infantile papulovesicular acrolocalized syndrome].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/371656" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Papular acrodermatitis of childhood and other papulo-vesicular acro-located syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16384769" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Gianotti-Crosti syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10869162" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Gianotti-crosti syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3015187" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Gianotti-Crosti syndrome: a study of 26 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5780747" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The Gianotti-Crosti syndrome: a distrinctive exanthem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/681797" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Infantile papular acrodermatitis (Gianotti's disease) and intrafamilial occurence of acute hepatitis B with jaundice: age dependency of clinical manifestations of hepatitis B virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/56530" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : An epidemic of infantile papular acrodermatitis (Gianotti's disease) in Japan associated with hepatitis-B surface antigen subtype ayw.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6459711" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Detection of hepatitis B surface antigen subtype adr in an epidemic of papular acrodermatitis of childhood (Gianotti's disease).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8186509" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : An epidemic of infantile papular acrodermatitis (Gianotti-Crosti syndrome) due to Epstein-Barr virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15580215" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Five patients with localized facial eruptions associated with Gianotti-Crosti syndrome caused by primary Epstein-Barr virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Spatial-temporal case clustering in children with Gianotti-Crosti syndrome. Systematic analysis led to the identification of a mini-epidemic</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27103975" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Pityriasis Rosea, Gianotti-Crosti Syndrome, Asymmetric Periflexural Exanthem, Papular-Purpuric Gloves and Socks Syndrome, Eruptive Pseudoangiomatosis, and Eruptive Hypomelanosis: Do Their Epidemiological Data Substantiate Infectious Etiologies?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31134587" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Gianotti-Crosti syndrome (papular acrodermatitis of childhood) in the era of a viral recrudescence and vaccine opposition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11100026" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Histopathologic features seen in Gianotti-Crosti syndrome secondary to Epstein-Barr virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10365586" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Atypical Epstein-Barr virus infection associated with Gianotti-Crosti syndrome and Bell's palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9604462" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Gianotti-Crosti syndrome as a presenting sign of EBV-induced acute infectious mononucleosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9263306" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Gianotti-Crosti syndrome associated with Epstein-Barr virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2543617" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : [An association between hepatitis-B antigen-negative infantile papular acrodermatitis and Epstein-Barr virus infection].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26083843" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : [Skin disorder as an indication of viral infection].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25497917" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Epstein-Barr virus: dermatologic associations and implications: part I. Mucocutaneous manifestations of Epstein-Barr virus and nonmalignant disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28050291" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Unusual Presentation of Gianotti-Crosti Syndrome due to Epstein-Barr Virus Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26751677" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Gianotti-Crosti Syndrome following immunization in an 18 months old child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25034095" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Gianotti-Crosti syndrome associated with Ebstein-Barr virus and Parvovirus B-19 coinfection in a male adult: case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1552055" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Gianotti-Crosti syndrome: a retrospective analysis of 308 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3822937" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Acute hepatitis B in children with papular acrodermatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3989023" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Gianotti-Crosti syndrome associated with hepatitis B surface antigen (subtype adr).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/464619" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Papular acrodermatitis associated with hepatitis B virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/643417" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The Gianotti-Crosti syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6284809" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Gianotti-Crosti-like eruption associated with coxsackievirus A-16 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3773143" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Gianotti-Crosti syndrome associated with infections other than hepatitis B.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7793281" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Gianotti-Crosti syndrome associated with cytomegalovirus infection: report of one case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6318668" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Papular acrodermatitis with cytomegalovirus hepatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9383234" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Gianotti-Crosti syndrome associated with cytomegalovirus antigenemia after bone marrow transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27017141" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Gianotti-Crosti syndrome as presenting sign of cytomegalovirus infection: A case report and a critical appraisal of its possible cytomegalovirus etiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9608338" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Papular acrodermatitis of childhood related to poxvirus and parvovirus B19 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9686061" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : [Parvovirus B19 primo-infection and cold agglutinins].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9878981" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Gianotti-Crosti syndrome: clinical, serologic, and therapeutic data from nine children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8849065" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : [Gianotti-Crosti syndrome due to a mixed infection produced by the mumps virus and the parainfluenza virus type 2].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4070084" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Papular acrodermatitis of childhood associated with hepatitis A virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1178265" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : [Gianotti-Crosti's infantile papular acrodermatitis. Nosological relationship with viral hepatitis. A fatal outcome].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9875979" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Gianotti-Crosti syndrome related to rotavirus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16796645" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Skin manifestations with Rotavirus infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15605970" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Gianotti-Crosti syndrome following milkers' nodules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7880219" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Gianotti-Crosti syndrome and human immunodeficiency virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8772033" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Case report: Gianotti-Crosti syndrome associated with human herpesvirus-6 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12437548" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : A prospective case control study of the association of Gianotti-Crosti syndrome with human herpesvirus 6 and human herpesvirus 7 infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26067570" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Unusual Eruptions Associated with Mycoplasma pneumoniae Respiratory Infections: Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8573937" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Gianotti-Crosti syndrome in an adult after influenza virus vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22148034" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Gianotti-Crosti Syndrome Following Novel Influenza A (H1N1) Vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21920234" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Atypical Gianotti-Crosti syndrome following administration of the AS03-adjuvanted H1N1 vaccine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21554384" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Gianotti-Crosti syndrome after H1N1-influenza vaccine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9990393" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Gianotti-Crosti syndrome after measles, mumps and rubella vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11834856" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Combined vaccination by measles and hepatitis B vaccines: a new cause of Gianotti-Crosti syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17239149" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Gianotti-Crosti syndrome in a child following hepatitis B virus vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11841642" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Gianotti-Crosti syndrome preceded by oral polio vaccine and followed by varicella infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27943306" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : A case-control study on the association of pulse oral poliomyelitis vaccination and Gianotti-Crosti syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19067881" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Gianotti-Crosti syndrome following hepatitis A vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12808342" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Gianotti-Crosti syndrome following Japanese encephalitis vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29897138" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Case of Gianotti-Crosti syndrome following varicella zoster virus vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10923136" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : [Acute Mycoplasma pneumoniae infection: new cause of Gianotti Crosti syndrome].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15842406" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Gianotti-Crosti syndrome in an adult following recent Mycoplasma pneumoniae infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11003916" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : [Neonatal papular acrodermatitis (Gianotti-Crosti) and Bartonella henselae infection].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8800310" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Infantile acrodermatitis of Gianotti-Crosti and Lyme borreliosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1745633" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Papular acrodermatitis of childhood (Gianotti-Crosti disease).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12816156" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Gianotti-Crosti syndrome and allergic background.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27339179" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Is Gianotti-Crosti Syndrome Associated with Atopy? A Case-Control Study and a Postulation on the Intrinsic Host Factors in Gianotti-Crosti Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27339179" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Is Gianotti-Crosti Syndrome Associated with Atopy? A Case-Control Study and a Postulation on the Intrinsic Host Factors in Gianotti-Crosti Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12869049" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Truncal lesions do not exclude a diagnosis of Gianotti-Crosti syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15389198" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Lichenoid eruptions in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23372217" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Hemorrhagic Gianotti-Crosti Syndrome in a One and Half Month old Infant: An Extremely Unusual Presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6329107" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Gianotti-Crosti syndrome. A review of ten cases not associated with hepatitis B.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29723358" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Atypical Gianotti-Crosti syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15461758" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : The diagnostic criteria of Gianotti-Crosti syndrome: are they applicable to children in India?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/332578" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Immune response to hepatitis B virus in children with papular acrodermatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7971574" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : An unusual case of recurrent Gianotti-Crosti syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4082695" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : [Acrodermatitis papulosa eruptiva infantum as a prodrome in hepatitis B infection].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1184390" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : [Entity of the Gianotti-Crosti's syndrome and its relation to hepatitis B infection].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24470919" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Gianotti-Crosti syndrome, pityriasis rosea, asymmetrical periflexural exanthem, unilateral mediothoracic exanthem, eruptive pseudoangiomatosis, and papular-purpuric gloves and socks syndrome: a brief review and arguments for diagnostic criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26517103" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : The diagnostic criteria of pityriasis rosea and Gianotti-Crosti syndrome - a protocol to establish diagnostic criteria of skin diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10943817" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Update on selected viral exanthems.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
